6 Participants Needed

Neural Interface for Upper Limb Amputation

(PSI Trial)

EL
AN
MS
Overseen ByMelissa S Schmitt
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: VA Office of Research and Development
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial aims to help individuals with an upper limb amputation feel where their missing limb would be through nerve stimulation. Participants receive a special device, the Chronically Implanted Neural and Muscular Interface, which sends tiny electrical signals to the nerves, creating sensations similar to having a real hand. Researchers hope this can improve the control and feel of prosthetic limbs. The trial suits those who have had one arm amputated, possess healthy nerves in the remaining part, and have used a prosthetic for at least a month. As an unphased trial, it offers a unique opportunity for participants to contribute to groundbreaking research that could enhance prosthetic technology for future patients.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the study team to get a clear answer.

What prior data suggests that this neural interface is safe for upper limb amputees?

Research shows that using a Chronically Implanted Neural and Muscular Interface holds promise for safety in humans. This treatment employs Functional Electrical Stimulation (FES), which involves applying small electric currents to nerves. Studies have found that this type of nerve stimulation is usually well-tolerated and can increase comfort and reduce fatigue compared to methods like surface electromyography (sEMG).

Although specific data from this exact study is not yet available, the technology behind these neural interfaces has been studied for safety and ease of use. Users of similar systems report more frequent use of their prosthetic limbs with less discomfort. This suggests that the treatment is relatively safe and can enhance the daily lives of those with upper limb amputations.12345

Why are researchers excited about this trial?

Researchers are excited about the chronically implanted neural and muscular interface for upper limb amputation because it offers a groundbreaking approach to restoring sensation and function. Unlike standard prosthetic options, which primarily focus on mechanical movement, this treatment uses Functional Electrical Stimulation (FES) to directly interface with nerves and muscles, potentially allowing for more natural proprioceptive sensations. This novel mechanism of action could lead to a significant improvement in how amputees perceive and control their prosthetic limbs, making it a promising advancement in the field of limb restoration.

What evidence suggests that the Chronically Implanted Neural and Muscular Interface is effective for upper limb amputation?

Research shows that long-term implanted devices in nerves and muscles can enhance how upper limb amputees control prosthetic arms. In this trial, participants will receive the Chronically Implanted Neural and Muscular Interface to explore this potential. Studies have found that small electric currents, known as functional electrical stimulation, help create sensations that inform the brain about limb movement and position, similar to a natural hand. This method aims to improve the ability to "feel" and control a prosthetic arm, resulting in more natural movements. Early results suggest that this technology could significantly enhance prosthetic limb function, providing users with better control and a more intuitive experience. Previous patients successfully used these devices long-term to improve prosthetic control.12567

Who Is on the Research Team?

EL

Emily L Graczyk, PhD

Principal Investigator

Louis Stokes VA Medical Center, Cleveland, OH

Are You a Good Fit for This Trial?

This trial is for individuals with a single upper limb amputation who are medically fit for anesthesia, have been using a prosthesis fitted by a specialist for at least one month, and can follow the study protocol. They must have good nerve function in the remaining limb and be mentally competent to participate. Pregnant women or those not preventing pregnancy, non-English speakers, people unfit for surgery, with uncontrolled diabetes or severe pain that interferes with activities are excluded.

Inclusion Criteria

Willingness and availability to follow the study protocol
A psychologist has confirmed I'm mentally fit for the study.
My remaining limb has working nerves.
See 4 more

Exclusion Criteria

I am not healthy enough for surgery.
I am able to understand and agree to the study's requirements.
Pregnancy, or those who are of childbearing potential, unwilling to prevent pregnancy during the trial
See 5 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Implantation and Initial Testing

Participants are implanted with neural and muscular interfaces and undergo initial testing to characterize proprioceptive sensations using Functional Electrical Stimulation (FES).

4-8 weeks

Proprioceptive Sensation Characterization

Characterization of proprioceptive sensations elicited by peripheral nerve stimulation, including testing of time-varying Peripheral Nerve Stimulation (PNS) patterns and paired agonist-antagonist stimulation strategies.

6 months
Monthly visits for assessments

Mechanisms Investigation

Investigation of the mechanisms of stimulation-evoked proprioception, including motor block tests and Targeted Muscle Reinnervation.

6 months
Monthly visits for assessments

Integration with Motor Control

Integration of proprioceptive stimulation with motor control during posture matching tasks, including virtual reality tasks and psychometric dissimilarity rating tasks.

12 months
Monthly visits for assessments

Follow-up

Participants are monitored for safety and effectiveness after the main intervention phases.

6 months

What Are the Treatments Tested in This Trial?

Interventions

  • Chronically Implanted Neural and Muscular Interface
Trial Overview The study aims to create sensations of hand position and movement (proprioception) in amputees by stimulating nerves through Functional Electrical Stimulation (FES). It will test different stimulation placements to evoke proprioceptive sensations and develop advanced prosthetic controllers based on these findings.
How Is the Trial Designed?
1Treatment groups
Experimental Treatment
Group I: Chronically Implanted Neural and Muscular InterfaceExperimental Treatment1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

VA Office of Research and Development

Lead Sponsor

Trials
1,691
Recruited
3,759,000+

Published Research Related to This Trial

The novel Regenerative Peripheral Nerve Interface (RPNI) demonstrated reliable signal generation from a residual nerve after a 14-month maturation period, indicating its potential for effective control of neuroprosthetic limbs.
Electromyographic signals from the RPNI were consistent and strong, exceeding 4 mV, with no signs of muscle denervation or significant tissue damage, suggesting long-term viability and safety for patients.
Electrically stimulated signals from a long-term Regenerative Peripheral Nerve Interface.Langhals, NB., Woo, SL., Moon, JD., et al.[2020]
The Regenerative Peripheral Nerve Interface (RPNI) provides reliable and consistent signals for upper-limb neuroprosthetic control, maintaining a high signal-to-noise ratio for up to 1054 days in participants.
One participant achieved over 94% accuracy in real-time prosthetic performance for 604 days and completed complex tasks with 99% accuracy for 611 days, demonstrating the long-term efficacy of RPNIs in controlling prosthetic devices.
Long-term upper-extremity prosthetic control using regenerative peripheral nerve interfaces and implanted EMG electrodes.Vu, PP., Vaskov, AK., Lee, C., et al.[2023]
Current prosthetic treatments for upper limb amputation provide limited functionality compared to natural arms, leading to high abandonment rates despite good acceptance among motivated patients.
Recent advancements in neural interface technologies, both invasive and noninvasive, show promise for improving control and functionality of prostheses, potentially enhancing the quality of life for amputees.
Neural interfaces for control of upper limb prostheses: the state of the art and future possibilities.Schultz, AE., Kuiken, TA.[2011]

Citations

Neural Interfaces for Control of Upper Limb ProsthesesCurrent treatment of upper limb amputation restores some degree of functional ability, but this ability falls far below the standard set by the natural arm.
Neural Interface for Upper Limb Amputation (PSI Trial)The purpose of this study is to characterize proprioceptive sensations in the missing limb of upper limb amputees using nerve stimulation, and to develop ...
Long-term upper-extremity prosthetic control using ...This study demonstrates the potential of RPNIs and implanted EMG electrodes as a long-term interface for enhanced prosthetic control.
Robotic Prostheses and Neuromuscular InterfacesThese medical devices are recognized for providing mobility to the amputated limb and are categorized based on their activation system. Body-powered activation ...
Neural Enabled Prosthesis for Upper Limb AmputeesThe purpose of this study is to evaluate a new prosthetic system for transradial amputees called the neural-enabled prosthetic hand (ANS-NEPH).
Investigating the Feasibility and Safety of Osseointegration ...User experience: ONIs increase daily prosthesis use by ~6 hours compared to sEMG, with higher comfort and reduced muscle fatigue, while sEMG is ...
Upper limb prostheses: bridging the sensory gap - PMCThis review outlines the nature of the problems underlying sensory restitution, the engineering methods that attempt to address this deficit and the surgical ...
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of ServiceยทPrivacy PolicyยทCookiesยทSecurity